Renato Longhi

Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis.

R. Longhi, R. Mantegazza, F. Cornelio, 1999, The Journal of clinical investigation.